Plus Therapeutics Inc [NASDAQ: PSTV] gained 22.78% on the last trading session, reaching $0.79 price per share at the time. If compared to the average trading volume of 16.26M shares, PSTV reached a trading volume of 8524111 in the most recent trading day, which is
Plus Therapeutics Inc [NASDAQ: PSTV] price surged by 1.80 percent to reach at $0.01. The one-year PSTV stock forecast points to a potential upside of 89.47. The average equity rating for PSTV stock is currently 1.00, trading closer to a bullish pattern in the stock
Plus Therapeutics Inc [NASDAQ: PSTV] closed the trading session at $1.43. The stocks have a year to date performance of 24.35 percent and weekly performance of 156.23 percent. The stock has been moved at -12.80 percent over the last six months. The stock has performed
Plus Therapeutics Inc [NASDAQ: PSTV] traded at a high on Thursday, posting a 170.06 gain after which it closed the day’ session at $1.38. The results of the trading session contributed to over 353225871 shares changing hands. Over the past one week, the price volatility
Plus Therapeutics Inc [NASDAQ: PSTV] traded at a high on Tuesday, posting a 12.60 gain after which it closed the day’ session at $1.43. The results of the trading session contributed to over 23476451 shares changing hands. Over the past one week, the price volatility
Plus Therapeutics Inc [NASDAQ: PSTV] gained 311.43% or 1.09 points to close at $1.44 with a heavy trading volume of 345990209 shares. The daily chart for PSTV points out that the company has recorded -4.64% loss over the past six months. If we look at
Medications and diagnostic tools are developed by the biotechnology industry to treat health problems. To obtain FDA (Food and Drug Administration) approval, Biotech products usually require a great deal of research and money. Years can elapse before investors learn if a drug under development will
Copyright © 2024, Powered by Smart TechOne
